Mednet Logo

Would you start a mineralocorticoid receptor antagonist in patients with unilateral primary aldosteronism while they are awaiting adrenalectomy?

Goi et al., PMID 41045519
Community PollStarted

Would you start a mineralocorticoid receptor antagonist in patients with unilateral primary aldosteronism while they are awaiting adrenalectomy?

51 physicians have voted

Join Mednetto vote and see how they answered.

3 Answers
Mednet Member
Mednet MemberInvited Expert
Endocrinology · Johns Hopkins Department Of Endocrinology Diabetes And Metabolism
Answered on

It depends on their blood pressure and potassium levels. Some of our patients are already on MRA at the time of their diagnosis without a need to get off the medication. Others may be started or returned to MRA after completing their biochemical workup. We recommend stopping MRA on the day of surger...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Nephrology · Hospital of the University of Pennsylvania
Answered on

I usually keep the MRA therapy ongoing, and stop it only 24-48 hours prior to the surgery in anticipation of GA/possible hyperkalemia. If there are "non-Conn’s” related indications (DKD/CHF), we are switching over to finerenenone.

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Nephrology · The Dialysis Center At Waltham
Answered on

Yes, I keep them on MRA Therapy.

Join for free or sign in to see the full answer